serw-MX  [xml]  
 


    
 DeCS Categories

A08 Nervous System .
A08.637 Neuroglia .
A11 Cells .
A11.650 Neuroglia .
D01 Inorganic Chemicals .
D01.045 Alkalies .
D01.045.125 Carbonates .
D01.045.125.500 Lithium Carbonate .
D01.200 Carbon Compounds, Inorganic .
D01.200.275 Carbonic Acid .
D01.200.275.150 Carbonates .
D01.200.275.150.550 Lithium Carbonate .
D01.510 Lithium Compounds .
D01.510.475 Lithium Carbonate .
D02 Organic Chemicals .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.114 Butyrates .
D02.241.081.114.968 Isobutyrates .
D02.241.081.114.968.500 Fibric Acids .
D02.241.081.114.968.500.500 Clofibric Acid .
D02.355 Ethers .
D02.355.726 Phenyl Ethers .
D02.355.726.305 Fibric Acids .
D02.355.726.305.500 Clofibric Acid .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.392 Hydrocarbons, Alicyclic .
D02.455.426.392.368 Cycloparaffins .
D02.455.426.392.368.450 Cyclopentanes .
D02.455.426.392.368.450.350 Cycloleucine .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.654 Phenyl Ethers .
D02.455.426.559.389.657.654.305 Fibric Acids .
D02.455.426.559.389.657.654.305.500 Clofibric Acid .
D02.886 Sulfur Compounds .
D02.886.640 Sulfoxides .
D02.886.640.074 2-Pyridinylmethylsulfinylbenzimidazoles .
D02.886.640.074.249 Lansoprazole .
D02.886.640.074.249.500 Dexlansoprazole .
D02.886.640.074.500 Omeprazole .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.725 Pyridines .
D03.383.725.024 2-Pyridinylmethylsulfinylbenzimidazoles .
D03.383.725.024.249 Lansoprazole .
D03.383.725.024.249.500 Dexlansoprazole .
D03.383.725.024.500 Omeprazole .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.103 Benzimidazoles .
D03.633.100.103.034 2-Pyridinylmethylsulfinylbenzimidazoles .
D03.633.100.103.034.249 Lansoprazole .
D03.633.100.103.034.249.500 Dexlansoprazole .
D03.633.100.103.034.500 Omeprazole .
D10 Lipids .
D10.251 Fatty Acids .
D10.251.355 Fatty Acids, Unsaturated .
D10.251.355.255 Eicosanoids .
D10.251.355.255.100 Arachidonic Acids .
D10.251.355.255.100.300 Hydroxyeicosatetraenoic Acids .
D10.251.355.310 Fatty Acids, Essential .
D10.251.355.310.166 Arachidonic Acids .
D10.251.355.310.166.550 Hydroxyeicosatetraenoic Acids .
D12 Amino Acids, Peptides, and Proteins .
D12.125 Amino Acids .
D12.125.072 Amino Acids, Cyclic .
D12.125.072.170 Cycloleucine .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Lithium Carbonate .
CP-15,467-61 .
Dilithium Carbonate .
Eskalith .
Lithane .
Lithium Bicarbonate .
Lithobid .
Lithonate .
Lithotabs .
Micalith .
NSC-16895 .
Priadel .
Quilinorm-retard .
Bicarbonate, Lithium .
CP 15,467 61 .
CP15,46761 .
Carbonate, Dilithium .
Carbonate, Lithium .
NSC 16895 .
NSC16895 .
Quilinorm retard .
Quilinormretard .
A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. .
1.00
472808
 
Neuroglia .
Glial Cells .
Neuroglial Cells .
Cell, Glial .
Cell, Neuroglial .
Cells, Glial .
Cells, Neuroglial .
Glial Cell .
Neuroglial Cell .
Glia 16894 .
The non-neuronal cells of the nervous system. They not only provide physical support, but also respond to injury, regulate the ionic and chemical composition of the extracellular milieu, participate in the BLOOD-BRAIN BARRIER and BLOOD-RETINAL BARRIER, form the myelin insulation of nervous pathways, guide neuronal migration during development, and exchange metabolites with neurons. Neuroglia have high-affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitters, but their role in signaling (as in many other functions) is unclear. .
0.51
6526488
 
Clofibric Acid .
2-(4-Chlorophenoxy)-2-methylpropionic Acid .
NSC-1149 .
p-Chlorophenoxyisobutyrate .
p-Chlorophenoxyisobutyric Acid .
NSC 1149 .
NSC1149 .
Clofibrinic Acid .
An antilipemic agent that is the biologically active metabolite of CLOFIBRATE. .
0.42
111362
 
Omeprazole .
H 168-68 .
Omeprazole Magnesium .
Omeprazole Sodium .
Prilosec .
H 168 68 .
H 16868 .
Magnesium, Omeprazole .
Sodium, Omeprazole .
A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. .
0.42
1478365
 
Cycloleucine .
Aminocyclopentanecarboxylic Acid .
NSC 1026 .
1 Aminocyclopentanecarboxylic Acid .
Acid, 1-Aminocyclopentanecarboxylic .
Acid, Aminocyclopentanecarboxylic .
1-Aminocyclopentanecarboxylic Acid .
An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities. .
0.42
21185
 
Hydroxyeicosatetraenoic Acids .
Acids, Hydroxyeicosatetraenoic .
HETE 16822 .
Eicosatetraenoic acids substituted in any position by one or more hydroxy groups. They are important intermediates in a series of biosynthetic processes leading from arachidonic acid to a number of biologically active compounds such as prostaglandins, thromboxanes, and leukotrienes. .
0.41
53168
 
Dexlansoprazole .
2-((R)-((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole .
Dexilant .
Dexlansoprazole Sesquihydrate .
Lansoprazole, R-Isomer .
R-Lansoprazole .
T-168390 .
TAK 390MR .
TAK-390 .
TAK-390MR .
TAK390MR .
Lansoprazole, R Isomer .
R Lansoprazole .
R-Isomer Lansoprazole .
T 168390 .
T168390 .
TAK 390 .
TAK390 .
The R-isomer of lansoprazole that is used to treat severe GASTROESOPHAGEAL REFLUX DISEASE. .
0.41
055